<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3692545&amp;fmt=gif">

The Future of Pharmaceutical Psychedelics in Mental Health Treatment

Michael Brown
Michael Brown
Director for Counter Narcotics Technology


In this episode we speak with Erica Siegal, a licensed clinical social worker, professional harm reductionist community organizer, psychedelic-assisted psychotherapist, and founder of NEST Harm Reduction Consulting in California. She worked as a psychotherapist researcher on the phase two and phase three FDA approved MDMA assisted psychotherapy clinical trials from 2014 to 2019. 

Join us as we discuss: 

  • Emerging findings about psychedelic treatments for individuals with mental health issues 
  • The pace of psychedelic substance regulation on a state and federal level  
  • Psychedelic substance interventions in the case of opioid addiction treatments


Listen and subscribe on your favorite podcast player:

Apple Podcasts


Google Podcasts

To make sure you never miss an episode of The Opioid Matrix, subscribe on Apple Podcasts, Spotify, the website, or your favorite podcast player here: https://plinkhq.com/i/1625927161?to=page